News

Pharmabiz18m
Seminar on revised Schedule M at JIS University in Kolkata emphasizes urgent GMP compliance in Indian pharma
Peethaambaran Kunnathoor, Chennai Wednesday, July 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz18m
Govt. Schemes helped growth of medical devices exports to 88% in six years: Centre
Govt. Schemes helped growth of medical devices exports to 88% in six years: Centre: Gireesh Babu, New Delhi Wednesday, July 30, 2025, 08:00 Hrs [IST] The Schemes supporting develo ...
Pharmabiz18m
A culture of quality excipients has ushered in: Experts at IPEC India Annual Conference
A culture of quality excipients has ushered in as the pharmaceutical industry advances towards manufacturing super and complex generics which requires high precision levels of process controls, Good ...
Pharmabiz18m
DGTR initiates anti-dumping probe on imports of “Bromo OTBN” from China
DGTR initiates anti-dumping probe on imports of “Bromo OTBN” from China: Shardul Nautiyal, Mumbai Wednesday, July 30, 2025, 08:00 Hrs [IST] Aimed at safeguarding domestic indu ...
Pharmabiz18m
Indian nutraceutical companies grapple with a maze of global regulatory challenges
Indian nutraceutical companies grapple with a maze of global regulatory challenges: Nandita Vijayasimha, Bengaluru Wednesday, July 30, 2025, 08:00 Hrs [IST] Indian nutraceutical c ...
Pharmabiz15h
Elpis Biopharma inks MoU with National Cancer Centre Singapore to conduct translational cell therapy research in Singapore
Elpis Biopharma inks MoU with National Cancer Centre Singapore to conduct translational cell therapy research in Singapore: Singapore Tuesday, July 29, 2025, 17:00 Hrs [IST] Elpis ...
Pharmabiz16h
Akeso announces China NMPA accepts sNDA for ivonescimab in combo with chemotherapy to treat advanced squamous NSCLC
Akeso announces China NMPA accepts sNDA for ivonescimab in combo with chemotherapy to treat advanced squamous NSCLC: Honk Kong Tuesday, July 29, 2025, 16:00 Hrs [IST] Akeso, Inc., ...
Pharmabiz18h
Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat
Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat: New Taipei City Tuesday, July 29, 2025, 14:00 Hrs [I ...
Pharmabiz19h
Pristine Eye Hospitals to set up Centre of Excellence for Dry Eye, to combat digital eye strain crisis on July 30
Pristine Eye Hospitals to set up Centre of Excellence for Dry Eye, to combat digital eye strain crisis on July 30: Our Bureau, Bengaluru Tuesday, July 29, 2025, 12:45 Hrs [IST] Pr ...
Pharmabiz19h
L V Prasad Eye Institute study notes elderly undergoing cataract surgery lack medical insurance support
L V Prasad Eye Institute study notes elderly undergoing cataract surgery lack medical insurance support: Our Bureau, Bengaluru Tuesday, July 29, 2025, 13:15 Hrs [IST] L V Prasad E ...
Pharmabiz19h
Tata Elxsi & KAVIA AI ink strategic pact, bringing GenAI powered SDLC automation to healthcare enterprises among others
Tata Elxsi & KAVIA AI ink strategic pact, bringing GenAI powered SDLC automation to healthcare enterprises among others: Our Bureau, Bengaluru Tuesday, July 29, 2025, 12:30 Hrs [I ...
Pharmabiz19h
China NMPA accepts for review Bayer’s NDA for sevabertinib to treat adult patients with advanced non-small cell lung cancer NSCLC
China NMPA accepts for review Bayer’s NDA for sevabertinib to treat adult patients with advanced non-small cell lung cancer NSCLC: Berlin Tuesday, July 29, 2025, 13:00 Hrs [IST] ...